Search Results

91 - 100 of 985 items :

  • type 2 diabetes mellitus x
Clear All
Interrelations Between Inflammatory and Oxidative Stress Biomarkers in Obese Women with Two Complications (Hypertension, Diabetes)

, inflammation and blood lipids in obese, post-menopausal women with type 2 diabetes: a randomized, double-masked, crossover study. Clin Nutr 30(4): 443-449, 2012. 28. Shams M, Al-Gayyar M, Barakat E . Type 2 diabetes mellitus-induced hyperglycemia in patients with NAFLD and normal LFTs: Relationship to lipid profile, oxidative stress and pro-inflammatory cytokines. Sci Pharm 79(3): 623-634, 2011. 29. Osman MT, Rahman T, Ismail TS, Azlina AR, Nawawi H . Investigation of oxidative stress status in metabolic syndrome patients using lipid peroxidation biomarkers

Open access
Vildagliptin in the Treatment of Type 2 Diabetes Mellitus

. 22. Bolli G, Dotta F, Colin L, Minic B, Goodman M. Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin. Diabetes Obes Metab 11: 589-595, 2009. 23. Kothny W, Foley J, Kozlovski P, Shao Q, Gallwitz B, Lukashevich V. Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus. Diabetes Obes Metab 15: 252-257, 2013. 24. Fakhoury WK, Lereun C, Wright D. A meta-analysis of placebo

Open access
Metabolic and bone profile in postmenopausal women with and without type 2 diabetes: a cross-sectional study

, WANG Z, YANG T, YING H, ZHANG Y, LIU S. Bone regulates glucose metabolism as an endocrine organ through osteocalcin . International Journal of Endocrinology. 2015; 2015 :967673. 9. AMERICAN DIABETES ASSOCIATION. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes – 2018 . Diabetes Care 2018; 41 (Suppl. 1):S13-S27. 10. COMPSTON J. Type 2 diabetes mellitus and bone (Review). J Intern Med 2018; 283 : 140-153. 11. DUMITRU N., COCOLOS A., CARAGHEORGHEOPOL A., DUMITRACHE C., BRATU O.G, NEAGU T.P, DIACONU C.C, GHEMIGIAN

Open access
The Use of Continuous Glucose Monitoring System in Combination with Individualized Lifestyle and Therapeutic Recommandations on Glycemic Control of Type 2 Diabetes Patients

-associated weight gain? Diabetes Obes Metab 9: 209-17, 2007. 27. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-1350, 2001.

Open access
Relationship between HbA1c and capillary blood glucose self-monitoring in type 2 diabetics

more: Addressing clinical inertia in the management of type 2 diabetes mellitus . Diabetes Res Clin Pract. 2014; 105 (3):302–12. 4. SNOEK F. Barriers to good glycaemic control: the patient’s perspective. Int J Obes [Internet]. 2000; 24 :S12–20. 5. GONDER-FREDERICK LA, COX DJ, RITTERBAND LM. Diabetes and behavioral medicine: The second decade . J Consult Clin Psychol. 2002; 70 (3):611–25. 6. RUSHFORTH B, MCCRORIE C, GLIDEWELL L, MIDGLEY E, FOY R. Barriers to effective management of type 2 diabetes in primary care: Qualitative systematic review

Open access
Late Controlled Type 2 Diabetes Mellitus with Severe Acute Systemic Infection

References 1. International Diabetes Federation. (2016). Diabetes: Facts And Figures, retrieved from http://www.idf.org/about-diabetes/facts-figures. 2. Cheta, D. (2014). Diabetes complications: new explanations and solutions, AGIR, Bucuresti. 3. Serban, V. (2011). Tratat roman de boli metabolice 2. Timisoara: Brumar 4. Tolunay, O., Çelik, T., Çelik, Ü., Kömür, M., Tanyeli, Z., & Sönmezler, A. (2016). Concurrency of Guillain-Barre syndrome and acute transverse myelitis: a case report and review

Open access
Lack of Correlation of the Serum 25(OH) Vitamin D Levels with the Glycated Hemoglobin A1c and the Lipid Profile in Type 2 Diabetes Patients on Oral Antidiabetic Drugs – Preliminary Data

References 1 . Al - Shoume r, K. A. et al. Does insulin resistance in type 2 diabetes alter vitamin D status? -Prim. Care Diabetes, 7, 2013, № 4, 283-7. 2 . Bakalov, D., M. Boyanov, A. Tsakova, et al. Prevalence of deficiency and insufficiency of vitamin D in patients with type 2 diabetes mellitus on oral antidiabetic drugs. - Endocrinologia, 18, 2013, № 1, 19-26. (article in Bulgarian). 3 . Borissova, А. М. et al. Frequency of vitamin D deficiency and insufficiency in the Bulgarian population ≥ 20-80 years

Open access
The Necessity to Evaluate the Needs of Type 2 Diabetes Patients and Nursing Intervention

References 1. Trăilescu A, Șerban V. Diabetul zaharat: istoric si importanta. In: Tratat Român de Boli Metabolice. Șerban V. (ed). Editura Brumar, Timișoara, pp 66-67, 2010. 2. International Diabetes Federation. The global burden. IDF Diabetes Atlas 6th edn, 2014 update. Brussels, Belgium. Accessed on 10 January 2015 at: http://www.idf.org/diabetesatlas/5e/the-global-burden 3. Moța M, Moța E, Popa S. et al. The national study on the prevalence of diabetes mellitus, prediabetes, overweight, obesity, dyslipidemia

Open access
Sglt2 Inhibitors – Is the Paradigm in Type 2 Diabetes Mellitus Management Changing ?

dapagliflozin vs glipizide as add-on therapy in T2DM inadequately controlled on metformin: 4 year data. Diabetes 62[Suppl. 1] - 73rd ADA Scientific Sessions 2013, Chicago, poster #62-LB, 2013 4. Cefalu WT, Leiter LA, Yoon KH et al. Canagliflozin demonstrates durable glycemic improvements over 104 weeks versus glimepiride in subjects with type 2 diabetes mellitus on metformin. Diabetes 62[Suppl. 1] - 73rd ADA Scientific Sessions 2013, Chicago, poster #65-LB, 2013 5. Strojek K, Yoon KH, Hruba V, Elze M, Langkilde AM, Parikh S. Effect of

Open access
Diabetes Mellitus Type 2 in Hospitalized COPD Patients: Impact on Quality of Life and Lung Function

References 1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015. Available from: http://www.goldcopd.org/. 2. Mekov E, Slavova Y. Diabetes mellitus and metabolic syndrome in COPD - part 1: introduction and epidemiology. Thoracic medicine 2013;5(4):6-18. 3. Wandell P. Quality of life of patients with diabetes mellitus. Scand J Prim Health Care 2005;23:68-74. 4. Mishra G, Dhamgaye T, Tayade B, Amol B, Amit S

Open access